ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Findings at ESMO 2024 Highlighting the Benefit of Neoadjuvant Therapies"
Episode Synopsis
Important findings about the benefit of neoadjuvant therapies, especially those involving checkpoint inhibition, have been reported at the ESMO 2024 Congress. Rebecca Dent MD, Scientific Chair of the meeting, as well as Medical Oncologist and Deputy Chief Executive Officer at the National Cancer Center, Singapore (with a special interest in all aspects of triple-negative breast cancer), shared the key areas of progress covered by the meeting.
In God we trust